The epilepsy device market is experiencing significant growth, driven by technological advancements, increased demand for non-invasive treatments, and AI-powered solutions.Austin, Dec. 13, 2024 (GLOBE ...

The global pain management devices market is estimated to flourish at a CAGR of 6.4% from 2021 to 2028. Transparency Market ...

Cala Health has finalised the initial closing of an oversubscribed growth round of $50m to support the expansion of patient access to its neurostimulation therapy. Nexus NeuroTech Ventures and Vertex ...

SetPoint Medical’s vagus nerve stimulator offers another treatment option for patients who do not properly respond to ...

Dr. Basem Hamid, of Pearland, is a neurologist and pain medicine doctor who claimed he implanted the devices into patients ...

SetPoint Medical announced today that it filed with the FDA for premarket approval (PMA) of its neuroimmune modulation device.

After securing Medicare coverage for its wearable neurostimulator to help people control their hand tremors, Cala Health has ...

A 52-year-old Pearland man has agreed to pay $948,359.85 in a settlement after allegations of submitting false claims for the ...

Lungpacer Medical announced that it received FDA premarket approval for its flagship AeroPace neurostimulation system.

Lungpacer Medical’s AeroPace System uses neurostimulation via an electrode-containing cardiovascular-catheter and software-controlled system to contract and strengthen the diaphragm in patients on ...

Medtronic Percept neurostimulators send electrical signals through thin wires to specific brain regions affected by ...

The publication of robust 1-year data helps position the Nalu Neurostimulation System as the standard of care in PNS and furthers the efforts of Nalu to achieve unencumbered access to PNS. It is ...